GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioton SA (OTCPK:BOIOF) » Definitions » Cyclically Adjusted PS Ratio

Bioton (Bioton) Cyclically Adjusted PS Ratio : (As of Jun. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Bioton Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bioton Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Bioton's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioton Cyclically Adjusted PS Ratio Chart

Bioton Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.82 1.04 1.02 0.79 0.86

Bioton Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.84 0.92 0.86 0.87

Competitive Comparison of Bioton's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Bioton's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioton's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bioton's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bioton's Cyclically Adjusted PS Ratio falls into.



Bioton Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bioton's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Bioton's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.108/149.0435*149.0435
=0.108

Current CPI (Mar. 2024) = 149.0435.

Bioton Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.230 101.180 0.339
201409 0.307 100.611 0.455
201412 0.328 100.122 0.488
201503 0.266 100.041 0.396
201506 0.281 100.448 0.417
201509 0.324 99.634 0.485
201512 0.085 99.471 0.127
201603 0.196 98.983 0.295
201606 0.223 99.552 0.334
201609 0.219 99.064 0.329
201612 0.161 100.366 0.239
201703 0.200 101.018 0.295
201706 0.247 101.180 0.364
201709 0.265 101.343 0.390
201712 0.329 102.564 0.478
201803 0.133 102.564 0.193
201806 0.245 103.378 0.353
201809 0.141 103.378 0.203
201812 0.175 103.785 0.251
201903 0.088 104.274 0.126
201906 0.208 105.983 0.293
201909 0.129 105.983 0.181
201912 0.155 107.123 0.216
202003 0.107 109.076 0.146
202006 0.144 109.402 0.196
202009 0.125 109.320 0.170
202012 0.262 109.565 0.356
202103 0.106 112.658 0.140
202106 0.105 113.960 0.137
202109 0.138 115.588 0.178
202112 0.120 119.088 0.150
202203 0.144 125.031 0.172
202206 0.138 131.705 0.156
202209 0.165 135.531 0.181
202212 0.223 139.113 0.239
202303 0.099 145.950 0.101
202306 0.141 147.009 0.143
202309 0.146 146.113 0.149
202312 0.137 147.741 0.138
202403 0.108 149.044 0.108

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bioton  (OTCPK:BOIOF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bioton Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Bioton's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioton (Bioton) Business Description

Industry
Traded in Other Exchanges
Address
Ul. Staro?ci?ska 5, Warszawa, POL, 02-516
Bioton SA is a Poland based company engaged in the principal business activity of manufacturing medicines and pharmaceutical preparations and production of pharmaceutical substances. The products of the company include recombinant human insulin in pharmaceutical substance form and as preparations for injections; glimepiride, an oral hypoglycemic drug; and metformin, an oral hypoglycemic drug. Its products line focuses on diet supplements, products for particular nutritional uses and cosmetics dedicated to patients with certain health problems. The group operates in Poland and internationally, of which majority of the revenue is derived from Poland.

Bioton (Bioton) Headlines

No Headlines